Literature DB >> 28871520

Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.

Shinya Okumura1, Toshimi Kaido2, Yuhei Hamaguchi1, Atsushi Kobayashi1, Hisaya Shirai1, Siyuan Yao1, Shintaro Yagi1, Naoko Kamo1, Etsuro Hatano1, Hideaki Okajima1, Kyoichi Takaori1, Shinji Uemoto1.   

Abstract

BACKGROUND: Visceral fat accumulation and muscle depletion have been identified as poor prognostic factors for various cancers. However, the significance of visceral adiposity and sarcopenic visceral obesity on outcomes after resection of pancreatic cancer remains unclear.
METHODS: A retrospective analysis of 301 patients who underwent resection for localized pancreatic cancer between 2004 and 2015 was performed. The extent of visceral adiposity [visceral to subcutaneous adipose tissue area ratio (VSR)] and visceral obesity [visceral fat area (VFA)] were measured on preoperative computed tomography images, together with skeletal muscle index (SMI) and muscle attenuation (MA). The impacts of these body composition parameters on outcomes after pancreatic resection were investigated.
RESULTS: The overall survival (OS) and recurrence-free survival (RFS) rates in patients with high VSR were significantly lower than those in patients with low VSR (P = 0.001, P = 0.007, respectively). There were no differences in OS and RFS between high VFA and low VFA group; however, when analyzed together with sarcopenic factors, OS and RFS rates of the patients with sarcopenic visceral obesity were significantly lower compared with those of the others. Multivariate analyses revealed that high VSR was an independent risk factor for mortality (hazard ratio (HR) 1.58, P = 0.009) and recurrence (HR 1.41, P = 0.026) together with low SMI, low MA, high CA19-9, microvascular invasion, and nodal metastasis.
CONCLUSIONS: Visceral adiposity and sarcopenic visceral obesity, as well as low muscle mass and quality, were closely associated with mortality and recurrence after resection of pancreatic cancer.

Entities:  

Mesh:

Year:  2017        PMID: 28871520     DOI: 10.1245/s10434-017-6077-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  32 in total

1.  Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.

Authors:  V Rodrigues; F Landi; S Castro; R Mast; N Rodríguez; A Gantxegi; J Pradell; M López-Cano; M Armengol
Journal:  J Gastrointest Surg       Date:  2020-07-13       Impact factor: 3.452

2.  Impact of the preoperative body composition indexes on intraoperative blood loss in patients undergoing pancreatoduodenectomy.

Authors:  Kenta Ishii; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Takashi Mizuno; Junpei Yamaguchi; Shunsuke Onoe; Nobuyuki Watanabe; Masato Nagino
Journal:  Surg Today       Date:  2020-06-20       Impact factor: 2.549

Review 3.  Hyperinsulinaemia in cancer.

Authors:  Emily J Gallagher; Derek LeRoith
Journal:  Nat Rev Cancer       Date:  2020-09-09       Impact factor: 60.716

4.  Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?

Authors:  Toshimi Kaido; Shuntaro Hirose; Yosuke Miyachi
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

5.  Prognostic Impact of Indicators of Systemic Inflammation and the Nutritional Status of Patients with Resected Carcinoma of the Ampulla of Vater: A Single-Center Retrospective Study.

Authors:  Yuji Shimizu; Ryo Ashida; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Katsuhisa Ohgi; Shimpei Otsuka; Akifumi Notsu; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2021-10-18       Impact factor: 3.352

6.  Body composition as reflected by intramuscular adipose tissue content may influence short- and long-term outcome following 2-stage liver resection for colorectal liver metastases.

Authors:  Toshimitsu Shiozawa; Yutaro Kikuchi; Tetsuji Wakabayashi; Kenichi Matsuo; Yuki Takahashi; Kuniya Tanaka
Journal:  Langenbecks Arch Surg       Date:  2020-08-26       Impact factor: 3.445

7.  Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.

Authors:  Yan-Chih Peng; Chien-Hui Wu; Yu-Wen Tien; Tzu-Pin Lu; Yu-Hsin Wang; Bang-Bin Chen
Journal:  Eur Radiol       Date:  2020-09-24       Impact factor: 5.315

Review 8.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

9.  Muscularity Defined by the Combination of Muscle Quantity and Quality is Closely Related to Both Liver Hypertrophy and Postoperative Outcomes Following Portal Vein Embolization in Cancer Patients.

Authors:  Siyuan Yao; Naoko Kamo; Kojiro Taura; Yosuke Miyachi; Sena Iwamura; Masaaki Hirata; Toshimi Kaido; Shinji Uemoto
Journal:  Ann Surg Oncol       Date:  2021-07-31       Impact factor: 5.344

10.  Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study.

Authors:  Lihu Gu; Yangfan Zhang; Jiaze Hong; Binbin Xu; Liuqiong Yang; Kun Yan; Jingfeng Zhang; Ping Chen; Jianjun Zheng; Jie Lin
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.